Group One Trading’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-238,327
| Closed | -$4.75M | – | 8404 |
|
|
2023
Q3 | $3.78M | Buy |
238,327
+142,766
| +149% | +$2.37M | 0.01% | 1119 |
|
|
2023
Q2 | $1.8M | Sell |
95,561
-123,642
| -56% | -$1.46M | 0.01% | 1800 |
|
|
2023
Q1 | $842K | Buy |
219,203
+80,145
| +58% | +$342K | ﹤0.01% | 2284 |
|
|
2022
Q4 | $690K | Buy |
139,058
+74,158
| +114% | +$402K | ﹤0.01% | 2755 |
|
|
2022
Q3 | $310K | Sell |
64,900
-15,741
| -20% | -$83K | ﹤0.01% | 3702 |
|
|
2022
Q2 | $363K | Sell |
80,641
-18,575
| -19% | -$80.7K | ﹤0.01% | 3721 |
|
|
2022
Q1 | $472K | Buy |
99,216
+53,287
| +116% | +$295K | ﹤0.01% | 3875 |
|
|
2021
Q4 | $341K | Sell |
45,929
-27,702
| -38% | -$172K | ﹤0.01% | 4540 |
|
|
2021
Q3 | $417K | Buy |
73,631
+60,162
| +447% | +$348K | ﹤0.01% | 4400 |
|
|
2021
Q2 | $89K | Buy |
+13,469
| New | +$94K | ﹤0.01% | 6079 |
|
|
2021
Q1 | – | Sell |
-53,713
| Closed | -$439K | – | 8154 |
|
|
2020
Q4 | $346K | Buy |
+53,713
| New | +$313K | ﹤0.01% | 3604 |
|
|
2020
Q3 | – | Sell |
-26,171
| Closed | -$106K | – | 6664 |
|
|
2020
Q2 | $120K | Buy |
26,171
+20,285
| +345% | +$86.3K | ﹤0.01% | 3765 |
|
|
2020
Q1 | $20K | Buy |
+5,886
| New | +$25.7K | ﹤0.01% | 4239 |
|
|
2019
Q2 | – | Sell |
-103,695
| Closed | -$245K | – | 5512 |
|
|
2019
Q1 | $281K | Sell |
103,695
-425
| -0.4% | -$1.84K | ﹤0.01% | 2437 |
|
|
2018
Q4 | $500K | Buy |
104,120
+81,592
| +362% | +$495K | ﹤0.01% | 1986 |
|
|
2018
Q3 | $213K | Sell |
22,528
-71,879
| -76% | -$691K | ﹤0.01% | 2975 |
|
|
2018
Q2 | $919K | Buy |
+94,407
| New | +$995K | 0.01% | 1799 |
|
|
2018
Q1 | – | Sell |
-9,230
| Closed | -$91.2K | – | 5419 |
|
|
2017
Q4 | $59K | Sell |
9,230
-12,003
| -57% | -$74K | ﹤0.01% | 3642 |
|
|
2017
Q3 | $162K | Buy |
+21,233
| New | +$141K | ﹤0.01% | 2908 |
|
|
2017
Q1 | – | Sell |
-120,173
| Closed | -$351K | – | 5108 |
|
|
2016
Q4 | $245K | Buy |
120,173
+68,121
| +131% | +$137K | ﹤0.01% | 2286 |
|
|
2016
Q3 | $140K | Buy |
52,052
+22,727
| +78% | +$66.1K | ﹤0.01% | 2719 |
|
|
2016
Q2 | $90K | Sell |
29,325
-3,640
| -11% | -$22.8K | ﹤0.01% | 2940 |
|
|
2016
Q1 | $281K | Buy |
32,965
+17,630
| +115% | +$149K | ﹤0.01% | 2096 |
|
|
2015
Q4 | $208K | Sell |
15,335
-22,689
| -60% | -$279K | ﹤0.01% | 2469 |
|
|
2015
Q3 | $365K | Buy |
+38,024
| New | +$556K | 0.01% | 2030 |
|
|
2015
Q2 | – | Sell |
-10,462
| Closed | -$115K | – | 5258 |
|
|
2015
Q1 | $94K | Sell |
10,462
-20,334
| -66% | -$147K | ﹤0.01% | 2944 |
|
|
2014
Q4 | $188K | Sell |
30,796
-19,067
| -38% | -$174K | ﹤0.01% | 2352 |
|
|
2014
Q3 | $528K | Buy |
49,863
+30,204
| +154% | +$342K | 0.01% | 1581 |
|
|
2014
Q2 | $233K | Buy |
19,659
+7,161
| +57% | +$89.9K | ﹤0.01% | 2269 |
|
|
2014
Q1 | $187K | Sell |
12,498
-33,282
| -73% | -$525K | ﹤0.01% | 2498 |
|
|
2013
Q4 | $672K | Buy |
45,780
+25,567
| +126% | +$393K | 0.01% | 1426 |
|
|
2013
Q3 | $344K | Buy |
20,213
+16,601
| +460% | +$292K | 0.01% | 1938 |
|
|
2013
Q2 | $60K | Buy |
+3,612
| New | +$58.5K | ﹤0.01% | 3267 |
|
Other funds holding IMGN
Group One Trading's IMGN Position: Q4 2023 in Review
Group One Trading sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 238,327 shares — an estimated $4.75M sold.
Group One Trading first reported a position in IMGN in Q2 2013 and held it in 33 quarters. The position peaked at $3.78M in Q3 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.
- Group One Trading reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
- Group One Trading sold 238,327 Immunogen Inc shares in Q4 2023, an estimated $4.75M.
- Group One Trading first reported a position in Immunogen Inc in Q2 2013 and held it in 33 quarters.
- Group One Trading's Immunogen Inc position peaked at $3.78M in Q3 2023.
- 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.
Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.